IN-HOSPITAL BLEEDING EVENTS WITH THE USE OF NEWER P2Y12 INHIBITORS IN REAL-LIFE PATIENTS WITH ACS: RESULTS FROM THE GREEK ANTIPLATELET (GRAPE) REGISTRY

Few comparative data exist on in-hospital bleeding events with the concurrent use of clopidogrel, prasugrel and ticagrelor in real-life patients with ACS undergoing percutaneous coronary intervention (PCI). We performed detailed recording of bleeding events (Bleeding Academic Research Consortium -